Encelimab Biosimilar - Research Grade

Human

LAG3ï؟½

5mg/ml

IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P18627

Blue ice

LAG-3 (LAG3) is an inhibitory immune checkpoint receptor expressed on activated T cells, where it restrains effector function and contributes to T-cell exhaustion. Targeting LAG3, this research-grade anti-human recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of encelimab supplied strictly for research use only (RUO). Manufactured under rigorous in vivo standards, the ultra-pure, low-endotoxin preparation is available in scalable milligram (mg) to gram (g) quantities to support heavy-usage, high-throughput laboratories. It serves checkpoint-blockade research, in vitro receptor-ligand and T-cell functional assays, in vivo tumor immunology models, and biologics characterization, functioning as a consistent control reagent throughout preclinical pipelines.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks